Literature DB >> 18359658

National comparative audit of the use of platelet transfusions in the UK.

H Qureshi1, D Lowe, P Dobson, J Grant-Casey, E Parris, D Dalton, K Hickling, F Waller, C Howell, M F Murphy.   

Abstract

The objective of this national audit was to examine the use of platelet transfusions against audit standards developed from national guidelines. Hospitals were asked to provide data on 40 consecutive patients receiving platelet transfusions (15 haematology patients, 10 cardiac, 10 critical care and five in other clinical specialties). One hundred and eighty-seven UK hospitals participated, including 168/263 (64%) hospitals in England. A total of 4421 patients receiving platelet transfusions were audited. The reason for transfusion was documented in the medical records for 93% of transfusions and 57% were used for prophylaxis (in the absence of bleeding). Overall 3726/4421 (84%) of the transfusions were evaluable and 43% (1601/3726) were found to be non-compliant with the audit standards. A major non-compliance was failure to measure the platelet count before transfusion (29% of transfusions). Other non-compliances included the use of platelet transfusion in the absence of bleeding in 11% of cardiac surgery patients receiving platelet transfusions, the use of a threshold platelet count more than 10 x 10(9)/L for 60% of prophylactic platelet transfusions in haematology patients without risk factors indicating the need for a higher threshold, and a threshold platelet count more than 30 x 10(9)/L for 59% of prophylactic platelet transfusions in critical care. The reasons for the high rate of non-compliance were not explored in this audit, but this is a topic worthy of further study. The main recommendations were that hospitals should ensure there are written local guidelines for platelet transfusions, clinicians must be provided with training about their appropriate use, and hospitals should carry out regular audits of practice. More research should be carried out to develop the evidence base for the use of platelet transfusions, more detailed guidelines should be developed for platelet transfusions in critical care and cardiac surgery, and the audit should be repeated in about three years.

Entities:  

Mesh:

Year:  2008        PMID: 18359658     DOI: 10.1016/j.tracli.2008.01.002

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  16 in total

1.  Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.

Authors:  John P Pitman; Sridhar V Basavaraju; Ray W Shiraishi; Robert Wilkinson; Bjorn von Finckenstein; David W Lowrance; Anthony A Marfin; Maarten Postma; Mary Mataranyika; Cees Th Smit Sibinga
Journal:  Transfusion       Date:  2015-02-27       Impact factor: 3.157

2.  Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.

Authors:  Lise J Estcourt; Callum Ingram; Carolyn Doree; Sally Hopewell; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02

3.  Transfusion practice and guidelines in Australian and New Zealand intensive care units.

Authors:  A Westbrook; V Pettilä; A Nichol; M J Bailey; G Syres; L Murray; R Bellomo; E Wood; L E Phillips; A Street; C French; N Orford; J Santamaria; D J Cooper
Journal:  Intensive Care Med       Date:  2010-05-04       Impact factor: 17.440

4.  Health outcomes in recipients of blood transfusion - observational studies versus randomized clinical trials.

Authors:  Edward L Murphy
Journal:  ISBT Sci Ser       Date:  2013-06-01

5.  Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm.

Authors:  Ali N Ali; Joanne Howe; Ahmed Abdel-Hafiz
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

6.  An audit of platelet transfusion indications in acute leukaemia patients: six-year experience at an Academic Centre.

Authors:  José C Jaime-Pérez; Gerardo García-Salas; Grecia A Turrubiates-Hernández; Dalila M Alvarado-Navarro; Luis J Marfil-Rivera; David Gómez-Almaguer
Journal:  Blood Transfus       Date:  2020-11-03       Impact factor: 3.443

Review 7.  Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.

Authors:  Lise J Estcourt; Callum Ingram; Carolyn Doree; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-05-24

Review 8.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon J Stanworth; Carolyn Doree; Sally Hopewell; Marialena Trivella; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18

Review 9.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Gemma L Crighton; Lise J Estcourt; Erica M Wood; Marialena Trivella; Carolyn Doree; Simon Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-09-30

Review 10.  Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Patricia Blanco; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.